Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes

Abstract To describe glucose metabolism in the late, weight stable phase after Roux-en-Y Gastric Bypass (RYGB) in patients with and without preoperative type 2 diabetes we invited 55 RYGB-operated persons from two existing cohorts to participate in a late follow-up study. 44 (24 with normal glucose...

Full description

Bibliographic Details
Main Authors: Nils B. Jørgensen, Kirstine N. Bojsen-Møller, Carsten Dirksen, Christoffer Martinussen, Maria S. Svane, Viggo B. Kristiansen, Jens J. Holst, Sten Madsbad
Format: Article
Language:English
Published: Nature Portfolio 2019-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-019-51516-y
_version_ 1818998911419809792
author Nils B. Jørgensen
Kirstine N. Bojsen-Møller
Carsten Dirksen
Christoffer Martinussen
Maria S. Svane
Viggo B. Kristiansen
Jens J. Holst
Sten Madsbad
author_facet Nils B. Jørgensen
Kirstine N. Bojsen-Møller
Carsten Dirksen
Christoffer Martinussen
Maria S. Svane
Viggo B. Kristiansen
Jens J. Holst
Sten Madsbad
author_sort Nils B. Jørgensen
collection DOAJ
description Abstract To describe glucose metabolism in the late, weight stable phase after Roux-en-Y Gastric Bypass (RYGB) in patients with and without preoperative type 2 diabetes we invited 55 RYGB-operated persons from two existing cohorts to participate in a late follow-up study. 44 (24 with normal glucose tolerance (NGT)/20 with type 2 diabetes (T2D) before surgery) accepted the invitation (median follow-up 2.7 [Range 2.2–5.0 years]). Subjects were examined during an oral glucose stimulus and results compared to preoperative and 1-year (1 y) post RYGB results. Glucose tolerance, insulin resistance, beta-cell function and incretin hormone secretion were evaluated. 1 y weight loss was maintained late after surgery. Glycemic control, insulin resistance, beta-cell function and GLP-1 remained improved late after surgery in both groups. In NGT subjects, nadir glucose decreased 1 y after RYGB, but did not change further. In T2D patients, relative change in weight from 1 y to late after RYGB correlated with relative change in fasting glucose and HbA1c, whereas relative changes in glucose-stimulated insulin release correlated inversely with relative changes in postprandial glucose excursions. In NGT subjects, relative changes in postprandial nadir glucose correlated with changes in beta-cell glucose sensitivity. Thus, effects of RYGB on weight and glucose metabolism are maintained late after surgery in patients with and without preoperative T2D. Weight loss and improved beta-cell function both contribute to maintenance of long-term glycemic control in patients with type 2 diabetes, and increased glucose stimulated insulin secretion may contribute to postprandial hypoglycemia in NGT subjects.
first_indexed 2024-12-20T22:09:03Z
format Article
id doaj.art-c89f85eceece431b94a7343b2e988b5d
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-20T22:09:03Z
publishDate 2019-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c89f85eceece431b94a7343b2e988b5d2022-12-21T19:25:13ZengNature PortfolioScientific Reports2045-23222019-10-019111010.1038/s41598-019-51516-ySustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative DiabetesNils B. Jørgensen0Kirstine N. Bojsen-Møller1Carsten Dirksen2Christoffer Martinussen3Maria S. Svane4Viggo B. Kristiansen5Jens J. Holst6Sten Madsbad7Department of Endocrinology, Hvidovre HospitalDepartment of Endocrinology, Hvidovre HospitalDepartment of Endocrinology, Hvidovre HospitalDepartment of Endocrinology, Hvidovre HospitalDepartment of Endocrinology, Hvidovre HospitalDepartment of Surgery, Hvidovre HospitalFaculty of Health and Medical Sciences, University of CopenhagenDepartment of Endocrinology, Hvidovre HospitalAbstract To describe glucose metabolism in the late, weight stable phase after Roux-en-Y Gastric Bypass (RYGB) in patients with and without preoperative type 2 diabetes we invited 55 RYGB-operated persons from two existing cohorts to participate in a late follow-up study. 44 (24 with normal glucose tolerance (NGT)/20 with type 2 diabetes (T2D) before surgery) accepted the invitation (median follow-up 2.7 [Range 2.2–5.0 years]). Subjects were examined during an oral glucose stimulus and results compared to preoperative and 1-year (1 y) post RYGB results. Glucose tolerance, insulin resistance, beta-cell function and incretin hormone secretion were evaluated. 1 y weight loss was maintained late after surgery. Glycemic control, insulin resistance, beta-cell function and GLP-1 remained improved late after surgery in both groups. In NGT subjects, nadir glucose decreased 1 y after RYGB, but did not change further. In T2D patients, relative change in weight from 1 y to late after RYGB correlated with relative change in fasting glucose and HbA1c, whereas relative changes in glucose-stimulated insulin release correlated inversely with relative changes in postprandial glucose excursions. In NGT subjects, relative changes in postprandial nadir glucose correlated with changes in beta-cell glucose sensitivity. Thus, effects of RYGB on weight and glucose metabolism are maintained late after surgery in patients with and without preoperative T2D. Weight loss and improved beta-cell function both contribute to maintenance of long-term glycemic control in patients with type 2 diabetes, and increased glucose stimulated insulin secretion may contribute to postprandial hypoglycemia in NGT subjects.https://doi.org/10.1038/s41598-019-51516-y
spellingShingle Nils B. Jørgensen
Kirstine N. Bojsen-Møller
Carsten Dirksen
Christoffer Martinussen
Maria S. Svane
Viggo B. Kristiansen
Jens J. Holst
Sten Madsbad
Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
Scientific Reports
title Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
title_full Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
title_fullStr Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
title_full_unstemmed Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
title_short Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
title_sort sustained improvements in glucose metabolism late after roux en y gastric bypass surgery in patients with and without preoperative diabetes
url https://doi.org/10.1038/s41598-019-51516-y
work_keys_str_mv AT nilsbjørgensen sustainedimprovementsinglucosemetabolismlateafterrouxenygastricbypasssurgeryinpatientswithandwithoutpreoperativediabetes
AT kirstinenbojsenmøller sustainedimprovementsinglucosemetabolismlateafterrouxenygastricbypasssurgeryinpatientswithandwithoutpreoperativediabetes
AT carstendirksen sustainedimprovementsinglucosemetabolismlateafterrouxenygastricbypasssurgeryinpatientswithandwithoutpreoperativediabetes
AT christoffermartinussen sustainedimprovementsinglucosemetabolismlateafterrouxenygastricbypasssurgeryinpatientswithandwithoutpreoperativediabetes
AT mariassvane sustainedimprovementsinglucosemetabolismlateafterrouxenygastricbypasssurgeryinpatientswithandwithoutpreoperativediabetes
AT viggobkristiansen sustainedimprovementsinglucosemetabolismlateafterrouxenygastricbypasssurgeryinpatientswithandwithoutpreoperativediabetes
AT jensjholst sustainedimprovementsinglucosemetabolismlateafterrouxenygastricbypasssurgeryinpatientswithandwithoutpreoperativediabetes
AT stenmadsbad sustainedimprovementsinglucosemetabolismlateafterrouxenygastricbypasssurgeryinpatientswithandwithoutpreoperativediabetes